Report of 618 similar CTs, including 19968 ECs
 - 84% similar CTs used: exclusion criterion - one of the following - immediate need for chemotherapy in the opinion of the treating physician.
 - 75% similar CTs used: exclusion criterion - other - no concurrent pentoxifylline
 - 68% similar CTs used: inclusion criterion - for this reason and because cyclophosphamide hydrochloride used in this trial is known to be teratogenic, women of childbearing potential and men must agree to use adequate contraception (abstinence
 - 62% similar CTs used: inclusion criterion - hepatic - bilirubin normal sgot, sgpt, ggt, and alkaline phosphatase no greater than 2.5 times upper limit of normal no acute hepatitis
 - 61% similar CTs used: inclusion criterion - renal - creatinine no greater than 1.5 mg/dl (urinary diversion allowed)
 - 59% similar CTs used: inclusion criterion - single metastases that have been resected
 - 56% similar CTs used: inclusion criterion - hematopoietic - hemoglobin greater than 11 g/dl wbc greater than 4500/mm3 neutrophils greater than 1500/mm3 platelet count greater than 100,000/mm3
 - 48% similar CTs used: exclusion criterion - known seropositive for or active viral infection with human immunodeficiency vrus (hiv), hepatitis b virus (hbv) or hepatitis c virus (hcv).
 - 47% similar CTs used: exclusion criterion - allergic reaction to bortezomib
 - 44% similar CTs used: exclusion criterion - patients with history of bleeding cns metastasis will be excluded from the trial.
 - 44% similar CTs used: exclusion criterion - of this trial) negative cardiac work up (that is, echocardiogram, stress test).
 - 44% similar CTs used: inclusion criterion - all institutional, food and drug administration (fda), and national cancer institute (nci) requirements for human studies must be met
 - 32% similar CTs used: inclusion criterion - age greater than or equal to 18 years.
 - 25% similar CTs used: exclusion criterion - other - patients receiving chronic anticoagulant therapy will be excluded from the study.
 - 22% similar CTs used: ?clusion criterion - in first recurrence or relapse
